Citius Oncology (CTOR) Accounts Payables (2023 - 2026)

Citius Oncology's Accounts Payables history runs 4 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 71.34% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 71.34% YoY), while the FY2025 annual figure was $13.2 million, up 256.57% from the prior year.
• Accounts Payables was $2.2 million for Q1 2026 at Citius Oncology, down from $10.4 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $13.2 million in Q3 2025 to a low of $1.3 million in Q3 2023.
• Historically, Accounts Payables has averaged $6.6 million across 4 years, with a median of $6.8 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Accounts Payables surged 256.57% in 2025, then tumbled 71.34% in 2026.
• A 4-year view of Accounts Payables shows it stood at $1.3 million in 2023, then surged by 355.73% to $5.9 million in 2024, then surged by 77.83% to $10.4 million in 2025, then plunged by 78.94% to $2.2 million in 2026.
• The last three Accounts Payables figures came in at $2.2 million (Q1 2026), $10.4 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.